News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
ImClone Systems to Pay Abbott Laboratories $17.5 Million to End Lawsuit
August 11, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Aug. 8 (Bloomberg) -- ImClone Systems Inc., maker of the Erbitux cancer drug, agreed to pay Abbott Laboratories $17.5 million to end a patent-infringement lawsuit over the medicine.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Abbott Laboratories
MORE ON THIS TOPIC
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
·
2 min read
·
Nick Paul Taylor
Job Trends
As H-1B visa changes keep coming, biopharmas adjust hiring approach
October 22, 2026
·
5 min read
·
Angela Gabriel
Legal
‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma ban
October 14, 2026
·
4 min read
·
Annalee Armstrong
Manufacturing
Merck barred from making subcutaneous Keytruda in 8 European countries
October 8, 2026
·
2 min read
·
Nick Paul Taylor
